Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance

Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $131.14 million versus the consensus estimate of $131.87 million.

GUIDANCE:

Cellebrite DI Ltd. sees Q3 2026 revenue of $145-148 million, versus the consensus of $150.3 million.

Cellebrite DI Ltd. sees FY2026 revenue of $550-560 million, versus the consensus of $568 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• JPMorgan cut off lending activity for Situational Awareness - FT
• 1844 Resources closes private placement raising $947,650